These Healthcare stocks are trading higher:
-G Medical Innovations Holdings Ltd (GMVD) stock is trading at $3.50, a rise of $0.53, or 18.52%, on high volume. G Medical Innovations Holdings L gets a Sentiment Score of Bullish from InvestorsObserver.
-Babylon Holdings Ltd (BBLN) stock is trading at $6.73, a rise of $0.89, or 15.95%, on high volume. Babylon Hldgs Ltd gets a Sentiment Score of Bearish from InvestorsObserver.
-Medavail Holdings Inc (MDVL) stock is trading at $1.46, a rise of $0.19, or 14.96%, on average volume. Medavail Hldg Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.00. Medavail Hldg Inc next reports earnings on February 6.
-OncoSec Medical Inc (ONCS) stock is trading at $1.01, an increase of $0.15, or 14.96%, on moderate volume. Oncosec Medical gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.00.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-PAVmed (PAVMZ) stock is trading at $1.17, a loss of $0.26, or 18.18%, on high volume. Pavmed Inc Series Z WT gets a Sentiment Score of Bullish from InvestorsObserver.-Lifestance Health Group Inc (LFST) stock is trading at $8.60, a loss of $1.32, or 13.36%, on average volume. Lifestance Health Group Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $17.40. Lifestance Health Group Inc next reports earnings on February 6.
-Shineco Inc (SISI) stock is trading at $3.67, a drop of $0.57, or 13.34%, on high volume. Shineco Inc gets a Sentiment Score of Bearish from InvestorsObserver.
-Denali Therapeutics Inc (DNLI) stock is trading at $33.58, a decline of $4.97, or 13%, on high volume. Denali Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $80.50. Denali Therapeutics Inc next reports earnings on February 2.